Aug 11, 2025 · Today, Tahoe announced it has raised 30 million in new venture funding, led by Amplify Partners. Other investors include Databricks Ventures, Wing Venture Capital, General Catalyst, AIX Aug 11, 2025 · With the new capital, Tahoe is advancing its own therapeutic programs toward the clinic, while also launching a new model of strategic collaboration. The company will select a single partner, a pharmaceutical or AI company with complementary strengths, to access the forthcoming dataset. Aug 11, 2025 · Tahoe Therapeutics Inc., a startup using artificial intelligence to speed up medical research, today announced that it has closed a 30 million investment. Amplify Partners led the funding Aug 11, 2025 · Tahoe Therapeutics secured 30 million in new funding. This capital fuels the creation of a vast dataset for training AI models of human cells. Amplify Partners led the round. The company plans to generate one billion single-cell datapoints, mapping one million drug-patient interactions. Tahoe Therapeutics, which is building AI models of living cells, raised 30M led by Amplify Partners at a 120M valuation, taking its total funding to 42M — The Palo Alto, California-based company, now valued at 120 million, has developed a scalable way to quickly generate crucial biological data needed ... Aug 11, 2025 · Amplify Partners, a venture capital firm, led a 30m round in Tahoe Therapeutics, a biotechnology company, with participation from Databricks Ventures, Wing Venture Capital, General Catalyst, Civilization Ventures, Conviction, Mubadala Capital Ventures and AIX Ventures. Aug 11, 2025 · Tahoe Therapeutics, a Palo Alto biotech startup, raised 30 million in funding led by Amplify Partners, valuing it at 120 million and bringing total funding to 42 million.
